| ERBB2 | Epidermal growth factor receptor 2 |
| C-CAT | Center for Cancer Genomics and Advanced Therapeutics |
| GEJ | Gastroesophageal junction |
| TCGA | The Cancer Genome Atlas |
| ACRG | The Asian Cancer Research Group |
| MSI | Microsatellite instability |
| TMB | Tumor mutational burden |
| FFPE | Formalin-Fixed Paraffin-Embedded |
| N/A | Not applicable |
| RECIST | Response Evaluation Criteria in Solid Tumors |
| MSI-H | Microsatellite instability high |
| PR | Partial response |
| SD | Stable disease |
| PD | Progressive disease |
| NE | Not evaluated |
| CGP | Comprehensive genomic profiling |
| T-DXd | Trastuzumab deruxtecan |